文献速递食管与纵隔外科

黏膜下食管鳞癌的临床病理特征与预后因素

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma.
PubMed 文献 · Ann Thorac Surg · 2017-10-21

该研究纳入137例接受经胸食管切除及系统扩大淋巴结清扫的黏膜下食管鳞癌患者,按浸润深度分为SM1、SM2、SM3。淋巴结转移率分别为18.8%、30.5%、50.0%,5年总复发率21.9%,5年总生存率分别为83%、77%、59%。多因素分析显示黏膜下浸润深度(SM3)和肿瘤位置(上胸段)是独立预后因素。

要点

  • SM3和上胸段肿瘤是黏膜下食管鳞癌的独立不良预后因素。
  • 淋巴结转移不是黏膜下食管鳞癌患者预后不良的预测因素。
  • SM1肿瘤复发均为局部区域复发,SM2和SM3出现远处转移。

核心结论

  • 肿瘤位置(上胸段)和浸润深度(SM3)是黏膜下食管鳞癌更差的预后因素,但淋巴结转移不是预后不良的预测因素。

研究设计与样本

  • 回顾性纳入137例接受经胸食管切除及系统扩大淋巴结清扫的黏膜下食管鳞癌患者,按浸润深度分为SM1、SM2、SM3,采用单因素和多因素分析确定预后因素。

主要发现

  • 淋巴结转移率在SM1、SM2、SM3分别为18.8%、30.5%、50.0%。
  • 总体5年复发率为21.9%,SM1、SM2、SM3分别为9.4%、18.6%、34.8%。
  • SM1肿瘤均发生局部区域复发,SM2和SM3出现远处转移。
  • 5年总生存率在SM1、SM2、SM3分别为83%、77%、59%。
  • 多因素Cox回归显示黏膜下浸润深度(风险比2.51,95%置信区间1.37至4.61)和肿瘤位置(风险比2.43,95%置信区间1.18至4.63)为术前预后因素。

临床怎么用

  • 对于黏膜下食管鳞癌,应评估浸润深度(SM3)和肿瘤位置(上胸段)以识别预后较差的患者,可能需更积极的治疗策略。
  • 淋巴结转移状态不应作为判断黏膜下食管鳞癌预后不良的唯一依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prognoses of submucosal esophageal squamous cell carcinoma patients vary. Patients with favorable prognoses may receive less invasive or nonsurgical interventions, whereas patients with poor prognoses or advanced esophageal cancer may require aggressive treatments. We sought to identify prognostic factors for patients with submucosal esophageal squamous cell carcinoma, focusing on lymph node metastasis and recurrence. METHODS: We included 137 submucosal esophageal squamous cell carcinoma patients who had undergone transthoracic esophagectomy with systematic extended lymph node dissection. Submucosal tumors were classified as SM1, SM2, and SM3 according to the depth of invasion. Prognostic factors were determined by univariable and multivariable analyses. RESULTS: Lymph node metastasis was observed in 18.8%, 30.5%, and 50.0% of SM1, SM2, and SM3 cases, respectively. The overall 5-year recurrence rate was 21.9%; the rates for SM1, SM2, and SM3 tumors were 9.4%, 18.6%, and 34.8%, respectively. The SM1 tumors all recurred locoregionally; distant metastasis occurred in SM2 and SM3 cases. The 5-year overall survival rates were 83%, 77%, and 59% for SM1, SM2, and SM3 cases, respectively. On univariable analysis, lymph node metastasis, depth of submucosal invasion (SM3 versus SM1/2), and tumor location (upper thoracic versus mid/lower thoracic) were poor prognostic factors for overall survival. Multivariable Cox regression analyses identified depth of submucosal invasion (hazard ratio 2.51, 95% confidence interval: 1.37 to 4.61) and tumor location (hazard ratio 2.43, 95% confidence interval: 1.18 to 4.63) as preoperative prognostic factors. CONCLUSIONS: Tumor location (upper thoracic) and infiltration (SM3) are the worse prognostic factors of submucosal esophageal squamous cell carcinoma, but lymph node metastasis is not a predictor of poorer prognosis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Emi M, Hihara J, Hamai Y, et al. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 2017. PMID: 29033014. doi:10.1016/j.athoracsur.2017.06.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。